Delivery Order SPE2DX15D3020-SPE2DX24FPYJF

Award Date 9/5/24
Potential Completion Date 9/6/24
Potential Value $36K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order issued under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), valued at up to $999,999,999 through December 2025. The prime contractor is Amerisourcebergen Drug Corporation, a major pharmaceutical distributor to the U.S. federal government. The contract is for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a medical product, at a ceiling value of $11,992.36. The delivery order was awarded on August 23, 2024, with an ultimate...
This is a delivery order for the federal contract SPE2DX15D2100|SPE2DX24F32UP, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp., a major pharmaceutical distributor. The contract is for the supply of 0.5 ML VAXNEUVANCE syringes, with a ceiling value of $36,517.73 and a completion date of November 3, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a medical product, with a ceiling value of $16,544.55 and a completion date of February 27, 2025. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $17,038.94 order is for the vaccine product VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. The IDC has a ceiling value of up to $999,999,999 through December 2025 and provides a mechanism for DLA to efficiently procure a comprehensive range of medical commodities, including pharmaceuticals and vaccines,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,826.50, is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a vaccine product. The contract has a completion date of November 15, 2023 and is a firm fixed-price delivery order. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply VAXNEUVANCE 0.5 ML SYRINGE 0.5ML pharmaceutical products. The award, valued at $9,788.89, has an ultimate completion date of March 20, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp to provide a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,944.38 order is for VAXNEUVANCE 0.5 ML SYRINGE 0.0.5ML, a medical product. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a $16,474.26 delivery order contract awarded by the Medical Supply Chain branch of the U.S. Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of VAXNEUVANCE 0.5ML syringes, with a performance period ending on May 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a medical product, with a ceiling value of $19,840.50 and a period of performance through January 9, 2024. The contract is a firm-fixed-price delivery order, which is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,344.92, is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a medical product. It has an ultimate completion date of May 8, 2023. This contract award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at...
  • SPE2DX15D3020
    Indefinite Delivery Contract
  • SPE2DX15D3020-SPE2DX24FPYJF
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $35,616.11, is for the procurement of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a vaccine product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, for the supply of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is expected to be completed by September 6, 2024.

Generated 12/5/24, 9:04 AM